menu search

Eos energy: determining fair value based on current backlog and other growth expectations

Eos Energy is developing a novel zinc-based battery system that rivals, and has the potential to disrup...

January 31, 2022, 2:34 pm

Down 57% in a month, is there more pain for tg therapeutics stock?

The stock price of TG Therapeutics (NASDAQ: TGTX), a commercial stage biopharmaceutical company focused on the development of ...

January 31, 2022, 5:00 am

Down 57% in a month, is there more pain for tg therapeutics stock?

The stock price of TG Therapeutics (NASDAQ: TGTX), a commercial stage biopharmaceutical company focused on the development of ...

January 31, 2022, 5:00 am

Down 57% in a month, is there more pain for tg therapeutics stock?

The stock price of TG Therapeutics (NASDAQ: TGTX), a commercial stage biopharmaceutical company focused on the development of ...

January 31, 2022, 5:00 am

Madrigal pharmaceuticals to announce topline results from the phase 3 maestro-nafld-1 study of resmetirom on monday, january 31st

CONSHOHOCKEN, Pa., Jan. 30, 2022 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuin...

January 30, 2022, 4:00 pm

Madrigal pharmaceuticals to announce topline results from the phase 3 maestro-nafld-1 study of resmetirom on monday, january 31st

CONSHOHOCKEN, Pa., Jan. 30, 2022 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuin...

January 30, 2022, 4:00 pm

Madrigal pharmaceuticals to announce topline results from the phase 3 maestro-nafld-1 study of resmetirom on monday, january 31st

CONSHOHOCKEN, Pa., Jan. 30, 2022 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuin...

January 30, 2022, 4:00 pm

4 clinical catalysts on tap for relmada in 2022

RLMD is set to produce results in 2022 from four clinical trials of REL-1017, its novel antidepressant....

January 28, 2022, 1:06 pm

4 clinical catalysts on tap for relmada in 2022

RLMD is set to produce results in 2022 from four clinical trials of REL-1017, its novel antidepressant....

January 28, 2022, 1:06 pm

4 clinical catalysts on tap for relmada in 2022

RLMD is set to produce results in 2022 from four clinical trials of REL-1017, its novel antidepressant....

January 28, 2022, 1:06 pm

F-star therapeutics: best-in-class tetravalent bispecific antibody technology in cancers

The company's unique selling proposition is its novel, tetravalent bispecific antibody platform which has earned validation through partnership deals ...

January 27, 2022, 7:29 am

F-star therapeutics: best-in-class tetravalent bispecific antibody technology in cancers

The company's unique selling proposition is its novel, tetravalent bispecific antibody platform which has earned validation through partnership deals ...

January 27, 2022, 7:29 am

F-star therapeutics: best-in-class tetravalent bispecific antibody technology in cancers

The company's unique selling proposition is its novel, tetravalent bispecific antibody platform which has earned validation through partnership deals ...

January 27, 2022, 7:29 am

Diamedica therapeutics to present research at international stroke conference

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing ...

January 25, 2022, 8:43 am

Diamedica therapeutics to present research at international stroke conference

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing ...

January 25, 2022, 8:43 am

Diamedica therapeutics to present research at international stroke conference

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing ...

January 25, 2022, 8:43 am

Ketamineone changes name to wellbeing digital science

KetamineOne Capital Limited (LSE:CAPD) announced that the company will change its name to Wellbeing Digital Science Inc.  Wellbeing will continue to ...

January 24, 2022, 8:54 am

Ketamineone changes name to wellbeing digital science

KetamineOne Capital Limited (LSE:CAPD) announced that the company will change its name to Wellbeing Digital Science Inc.  Wellbeing will continue to ...

January 24, 2022, 8:54 am

Ketamineone changes name to wellbeing digital science

KetamineOne Capital Limited (LSE:CAPD) announced that the company will change its name to Wellbeing Digital Science Inc.  Wellbeing will continue to ...

January 24, 2022, 8:54 am

Algernon pharmaceuticals includes novel salt forms of dmt in its recent ip patent applications

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) told investors that it believes the company has "maximized" its intellectual property (IP) positi...

January 24, 2022, 8:22 am


Search within

Pages Search Results: